OTCMKTS:VTRLY Vitrolife AB (publ) (VTRLY) Stock Price, News & Analysis $9.50 0.00 (0.00%) As of 10/1/2026 Add Compare Share Share Stock Analysis Stock AnalysisChartNews and Trends About Vitrolife AB (publ) Stock (OTCMKTS:VTRLY) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Vitrolife AB (publ) alerts:Sign Up Key Stats Today's Range$9.50▼$9.5050-Day Range$9.50▼$9.5052-Week Range$9.50▼$18.55VolumeN/AAverage Volume1,517 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Vitrolife AB (publ) is a Sweden-based medical technology company focused on assisted reproductive technology and fertility care. The company develops, manufactures and sells products and services used in in vitro fertilization (IVF), including embryo culture media, laboratory consumables, cryopreservation solutions and equipment for fertility clinics and reproductive laboratories. Vitrolife also provides time-lapse embryo imaging and monitoring systems designed to support the selection and development assessment of embryos. Through its fertility genetics activities, including the Igenomix business, the company offers genetic testing and related services intended to support reproductive treatment decisions. Founded in the 1990s and headquartered in Gothenburg, Sweden, Vitrolife serves fertility clinics, laboratories, physicians and patients internationally through operations and distribution networks across Europe, North America, Asia and other global markets. Its shares are listed on Nasdaq Stockholm, and the company’s securities also trade in the U.S. over-the-counter market under the symbol VTRLY.AI Generated. May Contain Errors. Read More Receive VTRLY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Vitrolife AB (publ) and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. VTRLY Stock News HeadlinesVitrolife AB (publ) (VTRLY) Q2 2026 Earnings Call TranscriptJuly 16, 2026 | seekingalpha.comVitrolife AB (publ) GAAP EPS of SEK 0.95, revenue of SEK 857MJuly 16, 2026 | seekingalpha.comHow options let you do more with less capitalWould you rather spend $5,000 buying 100 shares of a $50 stock, or control those same 100 shares for a fraction of the cost? That's the core advantage options offer traders at every level. The Beginner's Guide to Options breaks down leverage, income strategies, and real trade examples in plain English — including a little-known approach many traders use to reduce costs and improve profit potential. Download your free copy before this offer expires.October 2 at 1:00 AM | Base Camp Trading (Ad)Report from the Annual General Meeting of Vitrolife AB (publ)May 5, 2026 | prnewswire.comVitrolife AB (publ) - Interim report Q1, 2026: Strong growth in Consumables and TechnologiesApril 23, 2026 | prnewswire.comNotice of the Annual General Meeting of Vitrolife AB (publ)April 1, 2026 | prnewswire.comVitrolife AB (publ) - Fourth quarter and full year report 2025February 3, 2026 | prnewswire.comInvitation to Vitrolife Group's presentation of the fourth quarter and full year report 2025January 20, 2026 | prnewswire.comSee More Headlines VTRLY Stock Analysis - Frequently Asked Questions How have VTRLY shares performed this year? Vitrolife AB (publ)'s stock was trading at $15.0650 at the start of the year. Since then, VTRLY stock has decreased by 36.9% and is now trading at $9.50. How do I buy shares of Vitrolife AB (publ)? Shares of VTRLY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryN/A Current SymbolOTCMKTS:VTRLY CIKN/A Webwww.vitrolife.com Phone46-3-17-21-80-00FaxN/AEmployees1,151Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free Report This page (OTCMKTS:VTRLY) was last updated on 10/2/2026 by MarketBeat.com Staff. From Our PartnersElon Warns "America Will Go Bankrupt". Trump's Plan Inside.National debt just crossed 40 trillion dollars, and Elon Musk says America is 1,000% going to go bankrupt with...American Hartford Gold | SponsoredMILLIONAIRE MASTERCLASS INVITE: AltucherJames Altucher says Elon Musk is preparing an unprecedented project set to surface on December 8th. Altuche...Paradigm Press | SponsoredHow options let you do more with less capitalWould you rather spend $5,000 buying 100 shares of a $50 stock, or control those same 100 shares for a fractio...Base Camp Trading | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredA new kind of civil war is coming after election day?Across America, AI-driven backlash is fueling protests, lawsuits, and moratoria that could reshape the politic...Stansberry Research | SponsoredThe end of AI data centers coming?Marc Chaikin's Power Gauge system flagged Micron before it soared 970 percent, Celestica before a 6,600 percen...Chaikin Analytics | Sponsored"How Much Can I Actually Spend Each Year With $2.5M Saved?"Having $2.5 million saved puts you ahead of most Americans, but how long it lasts depends on the decisions you...SmartAsset | SponsoredMajor Buy Alert Issued for October 31stKeith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 ...TradeSmith | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vitrolife AB (publ) Please log in to your account or sign up in order to add this asset to your watchlist. Share Vitrolife AB (publ) With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
